JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB2388

Anti-Bid antibody

Be the first to review this product! Submit a review

|

(6 Publications)

Rabbit Polyclonal BID antibody. Suitable for WB and reacts with Human samples. Cited in 6 publications.

View Alternative Names

BH3-interacting domain death agonist, p22 BID, BID

1 Images
Western blot - Anti-Bid antibody (AB2388)
  • WB

Unknown

Western blot - Anti-Bid antibody (AB2388)

Western blot analysis of Bid in Jurkat cells treated with anti-Fas for 6 hours. Western blot analysis of Bid in Jurkat cells treated with anti-Fas for 6 hours.

All lanes:

Western blot - Anti-Bid antibody (ab2388)

Predicted band size: 22 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB

applications

Immunogen

Synthetic Peptide within Human BID. The exact immunogen used to generate this antibody is proprietary information.

P55957

Specificity

This antibody detects full length (22 kDa) Bid.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>" } } }

Product details

This product is manufactured by BioVision, an Abcam company and was previously called 3172 Bid Antibody.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 Preservative: 0.01% Thimerosal (merthiolate) Constituents: PBS, 30% Glycerol (glycerin, glycerine), 0.5% BSA
Shipped at conditions
Blue Ice
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Bid also known as BH3-interacting domain death agonist or BID protein functions as a pro-apoptotic member of the Bcl-2 protein family. This protein plays a significant role in the apoptotic process by helping to mediate the release of cytochrome c from mitochondria an important step in this cell death pathway. Bid exists in cells as an inactive uncleaved form but upon activation a caspase cleaves it into a truncated form tBID. The molecular weight of Bid is approximately 22 kDa. It is commonly expressed in numerous tissues throughout the body contributing to its various apoptotic regulatory roles.
Biological function summary

Bid induces mitochondria-mediated apoptosis that significantly affects cellular homeostasis. Bid is not considered to be part of a permanent protein complex; instead it acts as a mobile activator bridging interactions between different proteins within the apoptotic pathway. Upon activation tBID interacts with other Bcl-2 family members like Bax and Bak which leads to mitochondrial membrane permeabilization and subsequent release of cytochrome c.

Pathways

Bid significantly influences apoptotic signaling under different cellular stress conditions. It plays important functions in both intrinsic and extrinsic pathways of apoptosis. Within the intrinsic pathway Bid links the external death receptor signals to the mitochondria-mediated apoptotic pathway. In addition to interacting with Bax and Bak Bid indirectly connects to the apoptosome complex facilitating caspase activation which ultimately results in cellular apoptosis.

Bid has strong associations with conditions characterized by deregulated apoptosis such as cancer and neurodegenerative diseases. For instance downregulation or dysfunction of Bid is noted in certain cancer types contributing to the evasion of apoptosis a hallmark of cancer. Moreover in neurodegenerative diseases where excess apoptosis leads to loss of neuronal cells Bid activity has shown to connect with the regulation of apoptosis through its interactions with key apoptotic proteins such as Bcl-2 and Bax. Understanding Bid's role provides potential therapeutic targets to either promote or inhibit apoptotic processes in disease treatment.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Induces caspases and apoptosis (PubMed : 14583606). Counters the protective effect of BCL2 (By similarity).. BH3-interacting domain death agonist p15. Induces caspase activation and apoptosis (PubMed : 15661737, PubMed : 32029622). Translocates to mitochondria following cleavage and disrupts the outer mitochondrial membrane leading to the release of cytochrome c (PubMed : 10480954, PubMed : 32029622, PubMed : 9727491).. Isoform 1. Induces ICE-like proteases and apoptosis.. Isoform 2. Induces ICE-like proteases and apoptosis.. Isoform 3. Does not induce apoptosis.. Isoform 4. Induces ICE-like proteases and apoptosis.
See full target information BID

Publications (6)

Recent publications for all applications. Explore the full list and refine your search

Cell death discovery 8:284 PubMed35690610

2022

Caspase-2 is a mediator of apoptotic signaling in response to gemtuzumab ozogamicin in acute myeloid leukemia.

Applications

Unspecified application

Species

Unspecified reactive species

Petra Hååg,Magnus Olsson,Jeremy Forsberg,Marita Lagergren Lindberg,Bo Stenerlöw,Dali Zong,Lena Kanter,Rolf Lewensohn,Kristina Viktorsson,Boris Zhivotovsky,Leif Stenke

International journal of molecular sciences 21: PubMed32784671

2020

Antitumor Efficacy of the Herbal Recipe Benja Amarit against Highly Invasive Cholangiocarcinoma by Inducing Apoptosis both In Vitro and In Vivo.

Applications

Unspecified application

Species

Unspecified reactive species

Rittibet Yapasert,Nirush Lertprasertsuk,Subhawat Subhawa,Juthathip Poofery,Bungorn Sripanidkulchai,Ratana Banjerdpongchai

Hypertension (Dallas, Tex. : 1979) 76:87-100 PubMed32475310

2020

Reduced Nhe1 (Na-H Exchanger-1) Function Protects ApoE-Deficient Mice From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysms.

Applications

Unspecified application

Species

Unspecified reactive species

Cong-Lin Liu,Xin Liu,Yunzhe Wang,Zhiyong Deng,Tianxiao Liu,Galina K Sukhova,Gregory R Wojtkiewicz,Rui Tang,Jin-Ying Zhang,Samuel Achilefu,Matthias Nahrendorf,Peter Libby,Xiaofang Wang,Guo-Ping Shi

Molecules (Basel, Switzerland) 25: PubMed32155880

2020

The Effects of Thunb and Wall Extracts on Breast Carcinoma Cell Proliferation, Migration, Invasion and Apoptosis.

Applications

Unspecified application

Species

Unspecified reactive species

Subhawat Subhawa,Teera Chewonarin,Ratana Banjerdpongchai

Frontiers in pharmacology 9:372 PubMed29725297

2018

1-Deoxynojirimycin (DNJ) Ameliorates Indomethacin-Induced Gastric Ulcer in Mice by Affecting NF-kappaB Signaling Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Xuehua Piao,Shuangdi Li,Xiaodan Sui,Lianyi Guo,Xingmei Liu,Hongmei Li,Leming Gao,Shusheng Cai,Yanrong Li,Tingting Wang,Baohai Liu

Journal of virology 89:5581-91 PubMed25740983

2015

Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Aya Shinozaki-Ushiku,Akiko Kunita,Maya Isogai,Takashi Hibiya,Tetsuo Ushiku,Kenzo Takada,Masashi Fukayama
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com